Items tagged with Diagnostics
Public call: Update of the WHO high-priority target product profiles for TB diagnostics (post)
The World Health Organization (WHO) is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation drug-susceptibility testing at peripheral centers.
WHO announces updated critical concentrations for susceptibility testing for rifampicin (post)
5 February 2021 | GENEVA - The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-line anti-TB drugs have been revised by the the World Health Organization (WHO). Critical concentrations for rifampicin have been lowered while those for isoniazid have been maintained at the present level. This update helps address the discordance observed between phenotypic and molecular methods to detect rifampicin resistance and improves the accuracy of DST. As a result patients with TB will have a more accurate diagnosis.
WHO announces updates on new molecular assays for the diagnosis of TB and drug resistance (post)
17 February 2021 | GENEVA - Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are expected, following key updates on new molecular assays, announced by the World Health Organization (WHO) in a Rapid Communication released today.
A mission to conquer TB and sleeping sickness in developing nations (post)
Developing reasonably priced, easy-to-use diagnosis kits that can swiftly and accurately detect infectious diseases in developing countries has become the main mission of Chie Nakajima and Kyoko Hayashida, as they seek to alleviate some of the hardship endured by poverty-stricken people.
Cochrane Special Collection: Diagnosing TB (post)
Cochrane Library releases updated Special Collection on diagnosing TB.
PET and CT scans provide keen views of lungs with active TB, and are better assessment tools than sputum tests (post)
In clinical trials, a time-honored but old-school way to determine if TB is being knocked out by antibiotics involves having study participants cough up phlegm for a sputum culture, a test that can gauge whether the bacteria are succumbing to—or resisting—treatment.
BATM develops molecular diagnostics test for TB (post)
Clinical trials of BATM’s new method for the rapid and comprehensive diagnosis of TB will be fully funded by the Stop TB Partnership.
New approach to blood-based TB diagnosis (post)
LOS ALAMOS, N.M., April 7, 2021 — Work at Los Alamos National Laboratory, in conjunction with its research partners, provides valuable new insights into the diagnosis of tuberculosis (TB) using blood tests. A paper in the journal PLOS ONE today demonstrates the role that host-pathogen interactions play in detecting key biomarkers in blood, facilitating the diagnosis of disseminated or sub-clinical TB disease.
Call for experts: Technical Advisory Group on TB Diagnostics and Laboratory Strengthening (post)
The World Health Organization (WHO) Global TB Program is announcing a call for experts to serve as members of the Technical Advisory Group on TB Diagnostics and Laboratory Strengthening to advise WHO on technical aspects related to the assessment and implementation of TB diagnostic tools and TB diagnostic strategies.
TRUENAT- rapid molecular testing for TB. It’s time to go global! (post)
08 April, Geneva, Switzerland: Good news for all countries wanting to bring rapid molecular testing for tuberculosis (TB) and resistance to rifampicin to peripheral laboratories with minimal infrastructure. The Stop TB Partnership has negotiated global access pricing for TruenatTM tests, a battery-powered molecular technology that can diagnose TB in one hour as well as test for resistance to the drug rifampicin.
Page 40 of 70 · Total posts: 0
←First 39 40 41 Last→